Paracelsus Medizinische Privatuniversität (PMU)

Forschung & Innovation
Publikationen

Irinotecan in combination with 5-fluorouracil and folinic acid or with cisplatin in patients with advanced gastric or esophageal-gastric junction adenocarcinoma: results of a randomized phase II study.

#2004
#ANNALS OF ONCOLOGY

PMU Autor*in
Johannes Bükki

Alle Autor*innen
C. Pozzo, C. Barone, J. Szanto, E. Padi, C. Peschel, Johannes Bükki, V. Gorbunova, V. Valvere, J. Zaluski, M. Biakhov, E. Zuber, C. Jacques, R. Bugat

Fachzeitschrift
ANNALS OF ONCOLOGY

Kurzfassung

Keywords

TRIAL, DOXORUBICIN, METASTATIC COLORECTAL-CANCER, HIGH-DOSE METHOTREXATE, PLUS SUPPORTIVE CARE, EUROPEAN-ORGANIZATION, ADJUVANT CHEMOTHERAPY, FLUOROURACIL FAILURE, COOPERATIVE GROUP, LEUCOVORIN